12.90
-1.23%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Guangdong Biolight Meditech Co
Its shares trade on Shenzhen under the ticker 300246.SZ. It has been listed since 19 July 2011. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.10bn and a net loss of CN¥69.4m. At that date it held total assets of CN¥2.52bn and shareholders' equity of CN¥1.14bn.
Guangdong Biolight Meditech Co., Ltd. engages in the research, development, production, sale, and service of medical device products. The company is headquartered in Zhuhai, Guangdong. The company went IPO on 2011-07-19. Its medical monitoring equipment includes monitoring equipment, electrocardiograph, pulse oximeters and central monitoring systems. Its hemodialysis products include hemodialysis machines, hemodialyzers, hemodialysis powders/dialysates and perfusion machines. The firm distributes its products in domestic and overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 19 Jul 2011
- Employees
- 1,378
- Website
- blt.com.cn ↗
Leadership
Pay as last reported
- Mr. Jinyuan YanChairman of the Board, President, since 2008CN¥619,800
- Ms. Wei XuChief Financial Officer, Director, since 2022
- Mr. Daoguo ZhangVice President, Director, since 2025
- Mr. Yongxing YangSecretary of the Board
- Mr. Dayuan ChenStaff Elected Director
- Mr. Xiaoming LiDirector, since 2012CN¥100,700
- Mr. Fengqiang SunDirector
- Mr. Jian ChenIndependent Director
- Mr. Jundong XueIndependent Director
- Mr. Zhenxin YangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Guangdong Biolight Meditech employs 1,378 full-time employees in Zhuhai, China.
- The company produces medical monitoring equipment like electrocardiographs and pulse oximeters.
- Guangdong Biolight Meditech distributes products domestically and overseas in the Health Care sector.
Weaknesses
- The company's headquarters is in Zhuhai, Guangdong, China, limiting its global reach.
- Guangdong Biolight Meditech has no mention of international expansion plans beyond current markets.
- The firm's product range is limited to medical monitoring and hemodialysis equipment.
Opportunities
- Guangdong Biolight Meditech can expand its hemodialysis product line in the growing Health Care market.
- The company may leverage its domestic market presence to enter new overseas markets.
- Increasing demand for medical monitoring equipment presents a key opportunity for Guangdong Biolight Meditech.
Threats
- The Health Care sector faces increasing regulatory challenges in China and overseas markets.
- Competition from established medical device manufacturers in the global Health Care industry is intense.
- Guangdong Biolight Meditech's reliance on a single sector, Health Care, poses a risk to business diversification.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.